"team appointed to conduct clinical trials of its insomnia products using Blake’s proprietary Zleepax™ formula"
This looks like a typical reversal play after a huge run up. The news from March 2 introduces the team behind the clinical study. There is a huge market for this. Could be a nice reversal play here.
www.otcmarkets.com
Outstanding Shares 31,597,572 a/o...
